SEARCH

SEARCH BY CITATION

References

  • 1
    Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82: 21459.
  • 2
    Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H. Incidence of primary cholangiocel-luar carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 24717.
  • 3
    Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 104955.
  • 4
    Kubo S, Kinoshita H, Hirohashi K, Hamba H. Hepatolithiasis associated with cholangiocarcinoma. World J Surg 1995; 19: 63741.
  • 5
    Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K, Nakano M. Hepatitis C virus antibody in patients with primary liver cancer(hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma)in Japan. Cancer 1993; 72: 6838.
  • 6
    Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, Tanaka T, Tanaka W, Nishigami T. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995; 76: 244956.
  • 7
    Altaee MY, Johnson PJ, Farrant JM, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991; 68: 20515.
  • 8
    Kuper H, Ye W, Broome U, Romelsjo A, Mucci LA, Ekbom A, Adami HO, Trichopoulos D, Nyren O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, of cirrhosis. Hepatology 2001; 34: 7148.
  • 9
    Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995; 92: 251925.
  • 10
    Tanaka H, Hiyama T, Okubo Y, Kitada A, Fujimoto I. Primary liver cancer incidence rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan. Cancer Causes Control 1994; 5: 615.
  • 11
    Tanaka H, Tsukuma H, Hori Y, Nakade T, Yamano H, Kinoshita N, Oshima A, Shibata H. The risk of hepatitis C virus infection among blood donors in Osaka, Japan. J Epidemiol 1998; 8: 2926.
  • 12
    Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark. Hepatology 1998; 28: 9215.
  • 13
    The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 27787.
  • 14
    Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T. Hepatitis B and C Virus, clonorchis sinensis for the risk of liver cancer: A case control study in Pusan, Korea. Int J Epidemiol 1996; 25: 93340.
  • 15
    Uchida T, Shikata T, Tanaka E, Kiyosawa K. Immunoperoxidase staining of hepatitis C virus in formalin-fixed, paraffin-embedded needle liver biopsy. Virchows Arch 1994; 424: 4659.
  • 16
    Fisher HP, Doppl W, Osborn M, Altmannsberger M. Evidence for a hepato-cellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Virchows Arch B Cell Pathol Incl Mol Pathol 1988; 56: 716.
  • 17
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H. The separate-lesion type combined hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002; 49: 8069.